Myeloid-derived suppressor cells in cancer: recent progress and prospects.
about
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingOvercoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint BlockadeEffect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive MicroenvironmentAdipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokinesSurgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceMyeloid cells in circulation and tumor microenvironment of breast cancer patientsLack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals.Myeloid-derived suppressor cells in sepsisAccumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancerGranulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor.Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous mannerClinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanomaCharacterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma.Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination.Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor CellsNano-enabled delivery of diverse payloads across complex biological barriers.A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model.TRAF3: a novel tumor suppressor gene in macrophages.Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells.Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model.HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyCirculating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentDynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model.Metabolic determinants of the immune modulatory function of neural stem cellsReduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.Prognostic potential of an immune score based on the density of CD8+ T cells, CD20+ B cells, and CD33+/p-STAT1+ double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentTropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic TherapyInhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis.Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic deliveryEscape from IFN-γ-dependent immunosurveillance in tumorigenesis.Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function.Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer.Myeloid-derived suppressor cell heterogeneity in human cancers.Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia.CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.
P2860
Q26742012-264AA607-6E3B-4B81-86FD-A3494F523263Q26769977-35A3B020-6831-41F1-8769-D525A683CE9FQ26864045-78E4D231-33CE-4485-8583-9B7B50E4C0F8Q27001148-6FA11C4E-121C-4992-AE5A-08E67E596782Q27345519-3E0B23EC-BA78-4963-85DE-539C23407BF2Q33729434-372BA2A4-6B17-4303-A7B4-617E623CA925Q33743997-3FDE6C5D-FB30-4D0F-A77D-F12EF25FBCD1Q33786718-E456F6A8-D0C4-4786-886D-1D08ADA71B9AQ33888808-7E75F327-D60B-4A45-952A-1E4F353FC4D3Q34387000-F4B7A0E1-0100-4FFB-BD78-BDD632EE7F30Q34457611-94EF95C6-9C0A-48DF-9406-84CB520A72FAQ35056718-AA4CC561-1221-4E45-B4C7-A87A064DFFE5Q35078852-4A81D5C5-97E9-4371-81D3-7DF5A2BB787EQ35507112-8503B228-9B79-4042-A3EE-169444D42E45Q35693324-B3F12EFC-8FD4-41F5-A714-D818FEE52572Q36024656-662B040F-55D8-4892-B379-762106A314ECQ36061481-2E3EC06F-560A-40E3-A3BD-ACDAD33DD537Q36307467-C2D11B50-742B-4234-A814-D079F819F4C7Q36356265-2F703108-79E3-4413-BCF3-56381081E925Q36357661-C274D673-5D4B-4938-A76C-D3B3C7FCCED9Q36544867-6B00B977-E91A-49D4-9421-AC8EDB0CBDFBQ36561610-959E10DC-111F-4231-ABBB-E6102AF8CC97Q36568297-C4B624FD-EC39-4A77-8AE6-4B2BE72C9872Q36683267-2F7FD535-3069-4C38-86FA-E8678368EC99Q37107253-F0EB11BA-0021-4739-BD09-5FF47E87143BQ37228719-5EA23138-9E27-4BD2-A620-52B91D572BD2Q37235341-63C04CFE-1387-4004-910C-A993DC543C0BQ37402113-EF9ECDEE-0175-4FC3-810A-B24F8B0F2053Q37404693-3DF33C30-3EEB-422D-B7C5-C409637AE1F2Q37419153-CDA64655-6AAB-4531-9A4E-A9F588298BFFQ37421798-050047BB-7C6B-4F99-9464-2902B09F3465Q37497357-F968A670-0D83-44E2-B6B5-312F72A92AB5Q37618482-483DDFE9-6CC5-48F2-82E3-564713516723Q37637739-FE0F5EC1-A6F8-4D64-9BF9-5BA7F2BCA9B1Q37704869-E11C8C67-97A5-41E6-8D63-DA8E79A4E277Q37704877-885EE650-4B54-42C4-AF86-5A4BC02A370EQ38223250-E0EEC8B2-DEA3-4823-AEBE-700C1BB319B8Q38261210-EFCC356A-98AC-4A74-9E73-E045F0947385Q38294011-BF119823-2293-4717-B2DB-7E0FD186D8B8Q38299932-338FCEC9-51AC-4CE4-BD90-0FE78D0D321F
P2860
Myeloid-derived suppressor cells in cancer: recent progress and prospects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Myeloid-derived suppressor cells in cancer: recent progress and prospects.
@en
type
label
Myeloid-derived suppressor cells in cancer: recent progress and prospects.
@en
prefLabel
Myeloid-derived suppressor cells in cancer: recent progress and prospects.
@en
P2860
P356
P1476
Myeloid-derived suppressor cells in cancer: recent progress and prospects
@en
P2093
Basil J Ammori
P2860
P304
P356
10.1038/ICB.2013.29
P577
2013-06-25T00:00:00Z